© Copyright Nostre Net
The global cardiac catheterization market is accruing pervasively mainly due to the growing rate of cardiovascular disorders, worldwide. Currently, the world is witnessing the increasing number of cardiac disorders cases and issues related to heart diseases. Sadly, the figure is expected to grow every year; despite the several innovative therapies and procedures. The rising prevalence of these diseases is becoming a major concern fuelling the growth of the global cardiac catheterization market.
Acknowledging the fiercely ascending market, Market Research Future (MRFR) in its recently published study report asserts that the global cardiac catheterization market will continue to grow by 2023, registering a CAGR of 9.2% during the forecast period (2017-2023).
Rising technological advancements transpired in the field of heart care, bringing a diversity of engineering and design backgrounds, privacy, liability, and financial perspectives necessary to succeed in a complex health care system. Global Cardiac Catheterization market is growing as continuously increasing the patients suffering from arterial diseases. Changing lifestyle, an increasing number of the patient suffering from obesity and diabetes has also helped to expand the market of the cardiac medical device manufacturing.
Key Players:
Some of the eminent leaders of the market include Coloplast (Denmark), Boston Scientific Corporation (US), Dispocard GmbH (Germany), St. Jude Medical (US), Becton, Dickinson and Company (US), Abbott (US), Teleflex Incorporated (US)., Johnson & Johnson Private Limited (US), Smiths Medical (US), Medtronic Inc (US), Edwards Life Sciences Corporation (US), Rochester Medical Corporation (U.S), Terumo Medical Corporation (Japan), and Maquet Medical India Private Limited (India).
Cardiac Catheterization Market – Segments
The market is segmented into five Key dynamics for an easy grasp.
By Procedures : Balloon Septostomy, Coronary Angioplasty, Catheter Ablation, Bipolar Pacing, Left Heart Catheterization, and Right Heart Catheterization among others.
By Types : Fractional Flow Reserve, Coronary Angiogram, Intravascular Ultrasound, and Optical Coherence Tomography among others.
By Applications : Heart Attack, Abnormal Stress Test, Coronary Vasospasm, and Cardiac Arrhythmia, among others.
By End-Users : Hospitals and Clinics among others.
By Regions : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
Cardiac Catheterization Market - Regional Analysis
The North American region accounts for the global leader for the cardiac catheterization market owing to the increasing prevalence of cardiovascular diseases among the rising geriatric population, vulnerability to hypertension and obesity issues leading to the heart diseases and disorders. The market is constantly growing due to huge people suffering from major or minor heart issues.
Additional factors substantiating the market growth include increasing government initiatives and funding for research, rising demand for technologically advanced cardiac catheterization treatments, and the developments in advanced medical treatment options.
The European region is the second-largest market for cardiac catheterization. Attributing to the increasing healthcare expenditure and availability of advanced treatment facilities, along with the government initiatives of healthcare, the European market is estimated to register a phenomenal CAGR during the forecast period.
Cardiovascular disease is one of the major concerns in Europe; it significantly contributes to the market growth in this region. Growing rate of cardiovascular disorders alongside government initiatives are expected to positively impact the market growth of the cardiac catheterization market in this region.
The Asia Pacific region is rapidly emerging as a promising market for cardiac catheterization. Increasing geriatric population alongside the prevalence of cardiac disorders and diabetes growing at an alarming rate is fostering the market growth in the APAC region.
Global Cardiac Catheterization Market - Competitive Analysis
The market is fiercely competitive due to the presence of several large and small players forming a competitive edge in the market incorporating strategic partnership, collaboration, acquisition, expansion, and technology launch. Significant investments are transpired in the field to bring innovations to the therapy and clinical trials. High growth potential demonstrated by the market is likely to attract several new entrants, this, in turn, will result in intensifying the market competition further.
Hospitals are investing heavily in R&D and clinical trials to develop a comprehensive, efficient, and state-of-the-art cardiac catheterization facility to provide tailor-made transplant surgeries based on the ailments, age, and other complications. With advanced diagnostics, and comprehensive rehabilitation schedule these hospitals ensure that the patient has access to the best care at every stage of the transplant journey.
Market Insights
Original Equipment Manufacturers (OEMs) are witnessing an increased demand as the products they often manufacture vital for the completion of a finished healthcare product. With the healthcare sector evolving rapidly to adopt advancing technologies. OEMs are essentially responsible for the most instruments and devices used in the healthcare sector, including software designed specifically for healthcare use, thus consistently driving market growth as the requirements and demands are always changing. The increasing adoption of healthcare IT is another vital factor in encouraging healthcare OEM market growth. A growing emphasis on high-quality products and optimal utilization of resources which have led to reduced costs are some other drivers that will ensure market growth.
The global healthcare OEM market Share is set to witness a CAGR of USD 16.2% during the forecast period of 2017 to 2023. This projection among others has been made in Market Research Future's market report on healthcare OEM market. The global healthcare sector is booming with advancing technologies and a rising patient pool, thus driving the demand for a wide range of medical products. Valued at USD 160 Bn in 2016, the market is due to grow to reach an estimated evaluation of USD 250 Bn by the end of 2023.
Key Players
The global healthcare OEM market is highly competitive, and MRFR's market report includes several leading market players in its analysis. Key players include Dell, Tata Consultancy Services Ltd., Koninklijke Philips N.V., IBM Corporation, Wipro, Esaote SpA, Drägerwerk AG & Co. KGaA, Fujifilm Holdings Corporation, Allscripts Healthcare Solutions, Siemens Healthcare GmbH, Johnson & Johnson, Hitachi Medical Systems America, Inc., Xerox Corporation, Toshiba Medical Systems Corporation, Accenture Plc., Infosys Ltd., Baxter International, Aramark, GE Healthcare, and Cognizant Technology Solutions Corporation.
Market Segmentation
MRFR has performed an in-depth segmental analysis of the market on the basis of type, OEM solutions, application, and region. Based on the type, the market is segmented into healthcare software and medical device & instruments. Healthcare software is sub-segmented into billing & claims management, front/back-office operations, provider management, OT management, financial management, HR, and others. Medical device & instruments are further segmented into surgical, and diagnostic. Extensive analysis and further sub-segmentation on type can be found in MRFR's report.
By OEM medical solutions, the market is segmented into quality control & regulatory compliance, packaging & sterilization, manufacturing & fabrication, product design & development, technical support, project management, and order fulfillment & flexible distribution.
Based on applications, the market is categorized into dentistry, laboratory, veterinary, healthcare administration, surgery, dialysis, pharmaceutical & cosmetics, ophthalmology, and others. Global segmentation of the market includes the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Regional Analysis
Led by the U.S, the Americas account for close to 40% of the global market due to the presence of a large number of market players in the region. The presence of significant software sector which has many players operating in the healthcare field is a significant contributor to the regions market position. The growing demand for advanced healthcare IT solutions and other healthcare technology is expected to facilitate market growth.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Synopsis:
Market Research Future (MRFR)has published a detailed report stating that the global healthcare security systems market is marked to expand at a noteworthy CAGR of 9.5% during the forecast period of 2018-2024. Increased adoption of cloud-based solution of data storage and management in the healthcare sector is increasing the vulnerability of healthcare data towards theft and criminal activities. Rise in incidences of cybercrimes is inducing high demand for optimized security services, which in turn is propelling the expansion of the global healthcare security systems market. However, low penetration of advanced technology in underdeveloped regions and high cost of services are likely to act as restraining factors on the growth of the global healthcare security systems (HSS)market size.
Key Players:
Some of the key players profiled by MRFR that are operating in the global healthcare security systems market are Avigilon Corporation (Canada), Schneider Electric SE (the U.S.), Cisco Systems, Inc. (the U.S.), Tyco Security Products, Nedap Security Management, ADT LLC dba ADT Security Services (the U.S.), STANLEY Healthcare (France), Seico Security (the U.S.), Atos SE (Germany), Johnson Controls (the U.S.), Allied Telesis, Inc. (the U.S.), Siemens AG, Bosch Security Systems, Honeywell International, Inc., and others.
Market Segmentation:
The global hospital security systems market has been segmented on the basis of type, surveillance system, application, and end-user. Based on type, the global healthcare security systems market has been segmented into CCTV system, access control systems, infant security system, intrusion detection instruments, security alarm, metal and explosive detectors, RFID tags, and others. The access control systems segment has been sub-segmented into biometric systems, smart cards, chipper locks, and X-Ray screening system. The security alarm segment has been sub-segmented into burglar alarms, fire alarm, carbon monoxide alarm, and others. Based on surveillance system, the global healthcare security systems market has been segmented into video surveillance, surveillance cameras, and others. Based on application, the global healthcare security systems market has been segmented into surgical equipment tracking, medical devices tracking, document and data file tracking, patient tracking, monitoring, and others. Based on end-user, the global healthcare security systems market has been segmented into hospital, clinics, diagnostic centers, pharmacy, laboratories, and others.
Regional Analysis:
Geographically, the global healthcare security system market has been segmented into four major regions such as the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa. The Americas dominate the global healthcare security systems market with a significant market share. Rising cyber security threats, increased utilization of cloud-based solutions in the well-developed healthcare sector that require optimized security solutions and high risk of security to the medical data in the growing healthcare industry are fueling the growth of the healthcare security systems market in this region. Increased incorporation of advanced technology in the healthcare industry and high demand for effective healthcare security systems are leading to the notable expansion of the healthcare security systems market in the Europe region. Increasing reliance on cloud-based solutions in the healthcare sectors of emerging economies and rise in awareness regarding security threats to a large amount of healthcare data are propelling the expansion of the healthcare security systems market in the Asia Pacific region. However, low penetration of advanced technology and poor healthcare facilities in the underdeveloped countries are restraining the growth of the healthcare security systems market in the Middle East and Africa region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Proteins are necessary for the human body to perform various functions such as catalyzing metabolic reactions, DNA replication, responding to stimuli, and transporting molecules from one location to another. Therefore, the protein engineering market is lucrative. Protein engineering is required to produce biological compounds which include a storage protein, synthetic peptide, and the synthetic drugs that will be superior to a normal one and create an enzyme with superior properties to produce high-value chemicals in large quantities.
Market Research Future (MRFR) has published a research report about the global protein engineering market report that anticipates stable surge for this market with 6.2% CAGR (Compound Annual Growth Rate) for this market between 2017 and 2023. The most important factors driving the market include increasing demand for new technologies for the healthcare applications and the growth in research and development (R&D) activities for improving health outcomes using novel technologies. Other factors include the emergence of trends in protein identification & tracking and the increasing use of protein studies in R&D activities. Some factors that can put breaks on the market growth include expensive instruments used in protein engineering that require huge maintenance and lack of trained personnel.
Key Players
The key players in the global protein engineering market AB-Sciex (USA), Agilent Technologies (USA), Bio-Rad Laboratories Inc. (USA), Bruker Corp. (USA), GE Healthcare (UK), Perkin Elmer (USA), Sigma-Aldrich Corp. (USA), Thermo Fisher Scientific (USA), and Waters Corp. (USA).
The regional segmentation of the global protein engineering market segments the market into continent-based regional market namely the Americas (North America & South America), Europe, Asia-Pacific, and the Middle East and Africa (MEA). In the Americas, North America is a bigger market than South America due to advanced technology and better healthcare facilities. The Americas is the largest regional market as North America alone holds the potential to be the largest market due to its strong economies namely the United States of America (USA) and Canada. North America is a powerful market due to the presence of many major market players in this region, especially in the USA. Another important reason for the market growth in this region is the increase in the number of biotechnology and pharmaceutical companies. In the USA, extensive protein engineering technologies & methods and availability of technologically-advanced devices & instruments for research are also driving the market the market growth. In South America, Argentina and Brazil have strong economies, and they might emerge as big markets in the future.
According to the report, the Asia Pacific is expected to emerge as the fastest growing market during the forecast period. In this region, the market is driven by the need for new technologies with their application in healthcare and the rising prevalence of lifestyle diseases such as diabetes, heart diseases, obesity, etc. The primary country-specific markets in this region are Australia, China, India, Japan, and South Korea, followed by the rest of Asia Pacific.
The MEA region shows steady but positive growth with an increase in the demand for new drugs and devices for diagnosis as well as the treatment of diseases and improvement in healthcare infrastructure. The reasons for the slow market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, poor healthcare facilities, and healthcare not considered a priority by most governments. The crucial country-specific markets in this region are Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by the rest of the MEA region.
The amplified need to achieve communication with patients to monitor their health on a regular basis is driving the need for connected devices as well. Reports that examines the medical device industry has been offered by Market Research Future, which produces reports on industry verticals that evaluate the market development and opportunities. The market is projected to increase its market share with a positive CAGR in the coming years.
The need to achieve worthwhile and dependable patient monitoring systems is a major factor guiding the development of the market presently. Moreover, the escalated level of detection of chronic diseases and risk factors is expected to further urge market development to a greater degree in the forecast period. The expedited approval rate of the connected device market is estimated to benefit the expansion of the connected medical devices market analysis in the forthcoming period.
The distinguished contenders in the connected medical devices market are Medtronic Plc, OMRON Corporation, Philips Healthcare, GE Healthcare, Inc., iHealth Labs (subsidiary of Andon Health), Fitbit, Inc., Johnson & Johnson, Boston Scientific Corporation, F. Hoffmann-La Roche, St. Jude Medical, Inc. (Abbott), McKesson Corporation, AgaMatrix, Inc., Dexcom, Polar Electro, and Aerotel Medical Systems Ltd.
Segmental Analysis
The examination of the segments in the connected medical devices market has been conducted on the basis of device, product, application, region, and end-user. Based on the product, the connected medical devices market has been segmented into insulin pump, electromedical devices, ECG monitoring devices, BP monitor, glucose monitor, portable GPS pers, pulse oximeter, heart rate monitor, smart pill dispenser, and others. The device segment has been further divided into wearables and non-wearables. The application-based segmentation of the market comprises of consultation and diagnosis services, remote monitoring, treatment services, fitness, and wellness services. Based on end-user, the reprocessed medical devices market has been segmented into hospitals, specialty clinics, ambulatory surgical centers, home care settings/monitoring, and others. Based on the region, the connected medical devices market is segmented into the Asia Pacific, the Americas, Europe, and the Middle East & Africa.
Detailed Regional Analysis
The regional review of the connected medical device market observes that the Americas region is likely to govern the global associated medical devices market. The mounting prevalence of recurring diseases, mounting cognizance about the connected medical devices, promising policies from regulatory and government authorities, implementation of increasingly advanced technology and determined strategies implemented by major players in the market are encouraging the market growth. The European region market is projected to be the next chief connected medical devices market. The market development in this region can be accredited to government backing and backing of the healthcare sector connected with growing research and development. Furthermore, the upsurge in awareness about the connected medical devices is adding to the development of the market in this region. The Asia Pacific region is expected to display reasonable growth for connected medical devices market throughout the upcoming period owing to the growing occurrence of chronic diseases, mounting investments in healthcare and upsurge in implementation of new medical technologies in the region. The market in the Middle East & African region is anticipated to be responsible for the minimum share of the connected medical devices market owing to a weak healthcare sector, lack of technical expertise, and deprived medical facilities.
Market Highlights
The global Structural Health Monitoring market is projected to exhibit a CAGR of ~15% during the forecast period of 2022 to 2030.
The global Structural Health Monitoring market is projected to record a CAGR of ~15% during the forecast period. Structural Health Monitoring is a type of monitoring that will detect if there are any damages to the structures. Structural health monitoring can be applied to many different types of structures such as buildings, bridges, and pipelines. It can also be used on other objects such as aircraft and ships.
The COVID-19 outbreak has significantly impacted the global economy by disrupting production and demand, impacting the supply chain in the market. The government put a contingency plan in place by putting people inside their houses with no contact with the outside world. The government imposed a country-wide lockdown to minimize the risk of any further outbreaks.
There was a decrease in the demand for structural health monitoring market trends. During this pandemic, people were focusing on necessary items and were avoiding the unnecessary costs. This has decreased the demand for infrastructure projects. Furthermore, the government stopped all unnecessary activities that have stopped various construction and infrastructure projects.
Segmental Analysis
The global structural health monitoring market has been segmented based on offering, technology, end-use, and region. By offering, the global structural health monitoring market has been segmented into hardware, software & services. The software & services segment is anticipated to witness rapid growth in the global structural health monitoring market. As soon as the data arrives at the sensors, the software starts monitoring and analyzing its structure. The software provides the visual representation of the data on structural behavior and allows people to see the changes in real-time so that damages can be detected at the earliest. To do this, structures need to be monitored regularly. Structural health monitoring is crucial for any project with a large infrastructure. Structural failures are also increasing frequently, which is why this technology has become more urgent. To ensure the health and integrity of various structures and systems, one can use an approach based on the data collection from sensors installed around the building or machine. These include parameters related to loading, stress, strain and acceleration. Furthermore, it can be challenging for structural engineers to process and analyze such high volumes of data. To get around this, software platforms, apps, and other coding solutions are being adopted.
By technology, the global structural health monitoring market has been segmented into wired and wireless. The wired segment is expected to be the fastest-growing market in the global structural health monitoring industry. Today, many structures are being monitored with wired systems. These include bridges, buildings, and dams. The use of wired structural health monitoring systems has gained traction in the 21st century. These include the wires, cables, and fibers that enable the acquisition of data from sensors. It also enables communication with other devices. Wired network monitoring systems are good for many things including reducing data attenuation, being high-speed, the system having no limitation on transmission range, and the network having a high system bandwidth.nd for structural health monitoring systems. In other words, these systems can be used to maintain and monitor the condition of each structure and avoid catastrophic failures.
Regional Analysis
Geographically, the global structural health monitoring market has been categorized as North America, Europe, Asia-Pacific, and Rest of the World. In recent years, the North American market has seen enormous development in the structural health monitoring sector. Structural health monitoring has been transforming the way buildings are built and sustained. Companies have been using this service to detect and prevent structural issues such as building collapse, fire, or structural failure that can cost thousands of dollars to repair.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Highlights
Downstream processing refers to the series of operations required to derive pure and homogeneous protein products from biological materials such as cells, tissue culture fluid, or plant tissues. There is a high demand for the end products extracted by downstream processing, owing to the increasing applicationsin biopharmaceutical products. Thus, the downstream processing market trends is anticipated to observe significant growth during the forecast period.
According to MRFR analysis, the global downstream processing market growth is expected to register a CAGR of~16.09% from 2021 to 2027and hold a value of ~USD 61,174.53million by 2027.
Key Players
Some of the key players in the global downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation (US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG (Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi Kasei Corporation (Japan).
Segmentation
The global downstream processing market has been segmented into technique, product, application, and end user.
By technique, the market has been segregated into cell disruption, solid-liquid separation, clarification/concentration, purification techniques, and formulation. The purification techniques segment is further sub-segmented into ion exchange, affinity exchange, hydrophobic interaction, size exclusion chromatography, and others. The purification techniques segment held a significant share of the market in 2020, as it isone of the vital steps in downstream processing and has high product differentiation.
Based on the product, the global downstream processing market has been classified as chromatography columns &resins, filters, membrane adsorbers, and others. The chromatography columns &resinsis one of the most widely used product andwasestimated to bethe largest segment in 2020.
Based on application, the downstream processing market is segmented into antibiotic production, hormone production, antibodies production, vaccine production, and others. Antibiotic productionis one of the vital applications owing to increasing infectious diseases. Furthermore, the ongoing pandemic has created a huge demand for vaccine production globally which further supports the growth of the market.
Based on the end user, the downstream processing market is segmented into biopharmaceutical manufacturers, contract manufacturing organizations, and others. The biopharmaceutical manufacturers segment held the largest market share in 2020 due to increased R&D activities and production of biologics at a largescale, along with the rapidly growing biopharmaceutical industry.
Regional Analysis
By region, North America is anticipated to dominate the global downstream processing market, owing to well-established research organizations involved in research activities, the presence of a high number of contract manufacturing organizations (CMOs), and the presence of a largenumber of pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D investments by public and private players in the healthcare sectorfurther drives the market growth.
On the other hand, the European downstream processing market is driven by rising R&D expenditure by biopharmaceutical companies, increasing investments in the R&D sector, and the presence of key market players. For instance, in November 2019, Thermo Fisher Scientific, Inc. (US) announced that it is investing nearly USD 24 million in its Scotland site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell culture media.
Asia-Pacific is anticipated to be the fastest-growing market in the region over the assessment period due to growing and improving healthcare infrastructure, the establishment of research organizations, and increasing investments in biotechnology. In addition, factors such as the growing investments by key market players and the rapidly developing pharma and biopharma sector in the region are further driving the market.For instance, in April 2021, Asahi Kasei Corporation, a solution provider to the biologics manufacturing industry, expanded its business in China with the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview:
Molecular modelling is a strategy that involves computational techniques that integrates creation, manipulation, and representation of molecular structures. Based on this technology, a lot of drug can be developed. This process enables scientists to run various simulations that can ensure better results for the global drug development market. The global molecular modelling market share can achieve a CAGR of 15.93% during the forecast period 2027. Market Research Future (MRFR) discloses possibilities that can be explored well in the future to ensure strong growth in the coming years.
Various factors like hike in research-related investments, growing impact from pharmaceuticals to discover new drugs, technologies to develop personalized drug, better healthcare-related investments, growing cases of chronic disease, hike in budgets for healthcare sector, and other are expected to influence the global molecular modelling market. The burgeoning biosimilars and biologics industry is expected to take the market further ahead in the coming years.
Segmentation:
Product, application, and end-users are segments that have been included in the global molecular modelling market. This analysis is expected to provide in-depth analysis of various factors that can be used later to garner more profits in the coming years.
By product, the molecular modelling market comprises software and services. The software segment is generating substantial revenue and is expected to climb up with a 13.55% CAGR. But the services segment is expected to register the fastest CAGR of 18.64% within the same time frame.
Based on the application, the global molecular modelling market can be segmented into drug development, drug discovery, and others. the drug development segment can step ahead with 13.26% CAGR during the forecast period. The drug discovery segment is deemed to register the fastest CAGR of 17.30% over the assessment period.
By end-users, the molecular modelling market comprises research centers & academic institutions, pharmaceutical & biotechnological companies, and others. The pharmaceutical and biotechnological companies are expected to register a 13.84% growth during the forecast period, whereas, the research centers and academic institutions can post a CAGR of 19.16% during the review period.
Regional Analysis:
Region-wise analysis of the global molecular modelling market has four specific regions under its coverage. These regions are the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The report is all set to provide better demographic analysis to assist in the exploration of several possibilities that can impact the market growth in the future.
Technical superiority, robust infrastructure, high expenditure capacity, better research & development projects, and other healthcare-related initiatives are expected to provide strong traction to the regional market. The Americas is a region that includes two regions, North and South America. North America has better market scenario than South America.
Europe is sharing similar features like that of North America. These two regions are known for their research and development projects where development of new products and innovations are quite expected. The region is following North America closely in terms of market valuation. Several countries like the UK, France, Germany, and others are expected to promote the regional market.
The APAC market is expecting strong growth in the coming years with assistance from the hike in the market valuation of China, India, Thailand, Singapore, and others.
Competitive Landscape:
Prominent market players in the global molecular modelling market are Schrödinger, LLC, Cresset, Acellera Ltd., BioSolve-IT, Optibrium, Chemical Computing Group, Simulations Plus, Inc., Cambridge Crystallographic Data Centre OpenEye Scientific Software, Certara, L.P, Dassault Systèmes, and others. MRFR included these companies and profiled them for a better analysis of the global process. Such a report also includes various strategic moves taken by these companies. These moves are merger, acquisition, collaboration, and other methods.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global biopharmaceutical excipients market is driven by several factors, such as increasing demand for oral formulations across the globe, rising demand for customized medicines, and an increasing geriatric population. Other factors such as increasing patients with chronic ailmentscoupled with growing life expectancy are driving the production of biopharmaceuticals. In addition, increasing stress, back pains, body aches, and headaches has augmented the demand for topical type formulation, accelerating the market growth.
According to MRFR analysis, the global biopharmaceutical excipients market Growth is expected to register a CAGR of~6.8% from 2021 to 2027and is expected to hold a value of ~USD 3,114.6 million by 2027
The industry players focus on expanding their global footprint by strategic partnerships, investing in some company’s stock, acquisitions, and product launches. For instance, in February 2020, ReForm Biologics (US) partnered with MilliporeSigma (US) to commercialize excipients used in biotherapeutics. In August 2019, LBB Specialties (US) announced the strategic partnership with MEGGLE (Germany)to expand its excipient distribution channel across the US. In December 2018, Roquette (France) bought a majority stake in excipient producer Crest Cellose (India) that enabled the company to expand its product portfolio and presence in the Indian generic pharmaceutical market. Furthermore, the prominent players focus on new developments, employee satisfaction, the transformation of their research wings, and expanding their distribution network. These factors will augment the market growth and will increase theproduct demand in the forecast timeline.
Key Players
Some of the key players in the global biopharmaceutical excipients market are Merck KGaA (Germany), Colorcon (BPSI Holdings Inc) (US), BASF SE(Germany), Associated British Foods plc (UK), Signet Excipients Pvt. Ltd (IMCD) (Netherlands), Sigachi Industries Limited (Hyderabad), Spectrum Chemical Manufacturing Corp. (US), Roquette Frères (France), Clariant (Switzerland), DFE Pharma (Germany), J. Rettenmaier & Söhne Gmbh + Co Kg (Germany), and Evonik Industries AG (Germany).
Regional Analysis
North America is projected to dominate the biopharmaceutical excipients market due to the growing adoption of the latest drug manufacturing technologies, increasing chronic diseases, and expansion of production capabilities of the industry players across the region. In addition, highinvestments were made in the development of new excipient variants to advance the product portfolio. Furthermore, the key players are involved in collaborations, mergers, and R&D activities that propel market growth.
Europe embraces the second-largest position in the biopharmaceutical excipients market due to growing investments in the pharmaceutical sector and increasing production capacity across the region. In addition, the region experienced high demands for pharmaceutical products. Moreover, countries such asGermany, Italy, the UK, France, and Spain have invested huge amounts in the manufacturing of new vaccines.
Asia-Pacific is anticipated to be the fastest-growing regional market over the projected timeline due to the rising investment in pharmaceutical research and production facilities, increasing consumption of medicines, and supportive government alliances and subsidy schemes. In addition, the availability of highly skilled research employees and an economical workforce is creating opportunities for the industry players.
Furthermore, the market in the Rest of the World is gaining importance due to the rising number of investors, growing geriatric population in countries such as Chile and Argentina, and expansion of the pharmaceutical market across Latin America. However, the availability of counterfeit pharmaceutical goods is hampering the biopharmaceutical excipient market. The pharmaceutical companies aim atinvesting in the Middle East & Africaregion owing to its technologically advanced labs and other research infrastructures. Countries such as Saudi Arabia and the UAE are hiring employees throughout the globe to advance their pharmaceutical market.
Segmentation
The global biopharmaceutical excipients market is categorized into product and formulation. Based on the product category, the market has been segregated into solubilizers & surfactants/emulsifiers, polyols and carbohydrates, and specialty excipients. The carbohydrates segment is expected to hold a considerable share of the market in 2021. Increasing R&D activities for the development of lipid and protein excipient-based corona vaccines is fueling the market demand. In addition, the high demand for carbohydrate-based medicines for the infant segment is propelling the biopharmaceutical excipient market.
Based on formulation, the global biopharmaceutical excipients market has been classified as oral, topical, and injectables. The oral segmentheld the major share in 2020 due to the easy intake procedure and availability of oral medicines throughout the hospitals and retail stores. Additionally, the demand for oral and topical formulations is accelerating due to the growing preference for on-the-go treatment and ambulatory treatment services coupled with increasing cases of trypanophobia.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview
Tissues, cell lines, and cells are tested, characterized, stored, and collected by the cell banking outsourcing industry. These activities are carried out to aid in the production of biopharmaceuticals as well as research and development activities, ensuring minimal side effects and great efficacy. The technique for cell preservation entails initially proliferating cells, which subsequently multiply into a large number of identical cells, which are then stored in cryovials for future use. The production of regenerative medicine is essentially based on the use of cells. During the projection period of 2021 to 2027, the cell banking outsourcing market is estimated to reach USD 9476.9 million, growing at a CAGR of 15.6%.
Market Trends
During the forecast period, the cell banking outsourcing market growth is expected to rise due to an increase in the number of cell banks around the world. Another factor projected to drive market growth is the growing number of applications of cell-based products for research and therapeutics. Furthermore, a jump in the number of start-ups focusing on cell-based therapeutics and vaccine production is expected to drive market expansion. Similarly, the growing emphasis on regenerative and customized medicine is expected to fuel growth in the cell banking outsourcing industry. Due to well-established healthcare infrastructure, large patient populations, and significant healthcare expenditures, several key businesses focus on tailoring products and services to the American and European markets. There are no public cord blood banks in Africa, and importing cord blood units from other countries is prohibitively expensive for most patients. With first-to-market advantage, launching subsidiaries in developing regions can be advantageous.
Competitive Dynamics
The notable players of the market are CordLife (Singapore), Cleancells (France), Charles River Laboratories (US), BSL Bioservice (Germany), BioReliance (US), Sartorius (Germany), Covance (US), LifeCell International Pvt. Ltd. (India), Goodwin Biotechnology Inc. (US), GlobalStem Inc. (US), Cryo-Cell International Inc. (US), Lonza (Switzerland), PX’TherapeuticsSA (France), Wuxi Apptec (China), and the SGS fe Sciences (Switzerland).
Segmental Analysis
The global cell banking outsourcing market is divided into three categories: bank, cell, and application.
The market has been classified into three categories based on bank type: master cell banking, working cell banking, and viral cell banking. Because of its widespread utility, master cell banking is expected to have the largest market share in the worldwide cell banking outsourcing market.
The cell banking outsourcing market has been divided into stem cell banking and non-stem cell banking based on cell type. Because of its growing uses in regenerative medicine, the stem cell banking sector is expected to have the greatest market share in 2021.
Cell bank storage, cell bank preparation, and bank characterization and testing are the application segments of the cell banking outsourcing market.
Regional Overview
North America, Europe, Asia-Pacific, and the rest of the globe are the regions that make up the market.
Because of the greater adoption rates of novel technologies for the manufacturing of vaccines and therapeutic antibodies, North America is expected to have the greatest market share in 2021. Furthermore, the presence of various biopharmaceutical businesses in the region is expected to drive the cell banking outsourcing market in North America to new heights in the near future. North America is also likely to be a lucrative market due to the large number of research and development initiatives related to cytological inquiry for proteomics, genomics, and medication and vaccine development currently underway in the region. The growing demand for vaccines and biopharmaceuticals is expected to boost this region's growth.